E. Pezalla

发表

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

H. Eichler, G. Hirsch, S. Garner, 2012, Clinical pharmacology and therapeutics.

Secular trends in opioid prescribing in the USA

T. Mayne, J. Haddox, E. Pezalla, 2017, Journal of pain research.

Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need

G. Hirsch, S. Garner, R. Lim, 2016, Clinical pharmacology and therapeutics.

Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors.

E. Pezalla, D. Day, Indira Pulliadath, 2008, Journal of the American College of Cardiology.

Advancing Value Assessment in the United States: A Multistakeholder Perspective.

G. Sanders, M. Mcclellan, C. Sorenson, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Recognizing that Evidence is Made, not Born

I. M. Chen, H. Eichler, G. Hirsch, 2019, Clinical pharmacology and therapeutics.

Managed care interventions for improving outcomes in acute heart failure syndromes.

M. Gheorghiade, G. Fonarow, J. Dunn, 2008, The American journal of managed care.

Payer view of personalized medicine.

E. Pezalla, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The effect of the Medicare Part D benefit on medication management.

E. Pezalla, 2007, Managed care interface.

ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.

B. Solow, E. Pezalla, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014

W. Shrank, D. Solomon, N. Choudhry, 2016, Arthritis & rheumatology.

Intensification to triple therapy non-biologic disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States from 2009 to 2014

W. Shrank, D. Solomon, N. Choudhry, 2016 .

Hemophilia and managed care: Partnering to achieve cost-effective care

C. Kessler, S. Pipe, A. Shapiro, 2011 .

Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations.

L. Garrison, M. Recht, E. Sawyer, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.

T. Brennan, J. Avorn, Seth A. Berkowitz, 2014, JAMA internal medicine.

Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.

T. Brennan, J. Avorn, S. Schneeweiss, 2014, The American journal of medicine.

Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization.

E. Pezalla, W. Kwong, A. Petrilla, 2020, American health & drug benefits.

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

W Goettsch, D Samaha, S. Schneeweiss, 2015, Clinical pharmacology and therapeutics.

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget

R. Gani, K. Sutton, W. Meeraus, 2023, Vaccines.

Considerations for the optimal use of immunoglobulin.

M. Ballow, E. Pezalla, R. Navarro, 2012, The American journal of managed care.

Accelerated Access to Innovative Medicines for Patients in Need

J. Woodcock, H. Eichler, G. Hirsch, 2014, Clinical pharmacology and therapeutics.

Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications

R. Glynn, C. Spettell, W. Shrank, 2016, Annals of Internal Medicine.

Overview of alopecia areata for managed care and payer stakeholders in the United States

B. King, L. Takiya, J. Bourret, 2023, Journal of managed care & specialty pharmacy.

Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.

T. Brennan, J. Avorn, S. Schneeweiss, 2014, The American journal of medicine.

The Effect of a Pediatric Rare Disease on Subscriber Retention Rates for Commercial Health Insurers in the United States.

S. Nussbaum, E. Pezalla, Melanie K. Kuester, 2019, Journal of managed care & specialty pharmacy.